Home Alnylam bets on 'gene silencing' to woo biotech investors
 

Keywords :   


Alnylam bets on 'gene silencing' to woo biotech investors

2013-07-12 23:59:05| Biotech - Topix.net

A radical new treatment for genetic disorders has catapulted Alnylam Pharmaceuticals Inc into the crosshairs of investors seeking the next breakthrough name in biotechnology.

Tags: gene investors biotech woo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.06Cattle producers celebrate Supreme Court decision to rein in administrative overreach
28.06Diversified Labeling Solutions expands RFID capabilities
28.06Eastern North Pacific Tropical Weather Outlook
28.06Atlantic Tropical Weather Outlook
28.06Commitment leads to success in cattle marketing
28.06Kurz opens new facility in Germany
28.06Apex invests in Schepers laser engraving technology
28.06All4Labels opens first factory in Northeast Brazil
More »